Dubai Investments, a leading investment company listed on the Dubai Financial Market in the UAE, through its wholly owned subsidiary Globalpharma – UAE’s leading pharmaceutical manufacturer, has signed Memorandum of Understanding (MoU) with Angola’s Ministry of Health to establish a pharmaceutical manufacturing facility in Dubai Investments Park (DIP), Angola.
The MoU reflects the strengthened bilateral relations highlighted during the recent UAE delegation visit to Angola, led by Sheikh Mohamed bin Zayed Al Nahyan, President of the United Arab Emirates and Ruler of Abu Dhabi, underscoring both nations’ commitment to advancing collaboration and sustainable growth across key sectors.
As part of the MoU, Globalpharma will partner with Angola’s Ministry of Health to drive local production of medicines. The initiative is expected to create hundreds of jobs, enhance healthcare self-sufficiency, and reduce reliance on imported medical products — a key milestone in strengthening Angola’s healthcare ecosystem.
The MoU will formalise the support and facilitation extended by the Ministry for the successful implementation of DIP Angola’s projects. The Ministry of Health will coordinate with relevant government bodies to expedite the issuance of licenses, permits, and regulatory approvals, as well as facilitate access to available tax incentives, exemptions, and investment benefits, in accordance with national laws and investment promotion regulations.
